Delivery Order SPE2DB20D9637-SPE2DB22FC9NZ
Award Date 3/2/22
Potential Completion Date 3/23/22
Potential Value $9.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at $18,720.90 to DMS Pharmaceutical Group Inc. The order is for 1,000 vial units of KCENTRA to be delivered to a location in Park Ridge, Illinois, with performance required between September 29, 2023 and October 23, 2023. KCENTRA is a plasma-derived four-factor prothrombin complex concentrate indicated for the urgent reversal of acquired coagulation factor...
- The Defense Logistics Agency awarded a $14,404 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 1,000 vials of KCENTRA to be delivered by October 14, 2022. KCENTRA is a blood product used to treat patients with life-threatening bleeding episodes and for urgent warfarin reversal in life-threatening or uncontrolled bleeding. The Defense Logistics Agency leverages its bulk purchasing power and supply chain expertise to procure critical...
- The Defense Logistics Agency (DLA), a combat support agency within the Department of Defense, awarded a $29,959.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 1,000 vials of Kcentra. The product will be delivered from DMS's facility in Park Ridge, Illinois to an unknown DLA location by August 18, 2023. Kcentra is a blood coagulation factor replacement therapy used to treat patients with acquired coagulation factor deficiencies. This delivery order was issued against an...
- The Defense Logistics Agency Troop Support Medical awarded a $22,812 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562179656 KCENTRA 500 unit vials. DLA Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and medical supplies. This delivery order falls under an indefinite-delivery/indefinite-quantity contract vehicle and provides 500 vials of Kcentra, a four-factor prothrombin complex concentrate used to treat patients with acquired...
- The Defense Logistics Agency Troop Support Medical (DLA), a component of the U.S. Department of Defense, has awarded a firm fixed price delivery order valued at approximately $9,594 to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under this order, DMS will provide 1,000 vials of Kcentra to DLA by August 16, 2023 to support the agency's medical supply needs. Kcentra is a blood coagulation factor concentrate indicated for the urgent reversal of acquired coagulation factor deficiencies...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $32,740.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 1,000 vials of Kcentra under contract number 4561692664. Kcentra is an intravenous medication used to treat patients with serious bleeding or undergoing surgery who have certain bleeding disorders. DMS Pharmaceutical will deliver the Kcentra vials to a military treatment facility located in Park Ridge, Illinois...
- The Defense Logistics Agency awarded a $21,386 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to provide 4561904713 AB PT CMPLX CONC KCENTRA LAB services at a place of performance in Park Ridge, Illinois. The order was issued against an unspecified governmentwide acquisition contract vehicle to supply the concentrated solution used in treating patients with severe bleeding or coagulation problems from warfarin over-anticoagulation. Work under the order is to be completed by...
- The Defense Logistics Agency awarded a delivery order valued at $18,641.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 1,000 unit vials of Kcentra. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the blood coagulation factor KCENTRA, with a ceiling value of $60,532.48 and a completion date of February 22, 2024. The order was placed under DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA,...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at $16,324.80 to DMS Pharmaceutical Group Inc. The order is for 1,000 vial units of Kcentra to be delivered to a location in Park Ridge, Illinois. Performance will take place between June 29, 2023 and July 21, 2023 to supply the requested pharmaceutical product in support of the Agency's medical logistics programs. No subcontractors or set aside...
- SPE2DB20D9637Indefinite Delivery Contract
- SPE2DB20D9637-SPE2DB22FC9NZDelivery Order
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a $9,763 firm fixed price delivery order for 1,000 vial units of KCENTRA under an unidentified contracting vehicle. The place of performance is Park Ridge, Illinois and all items are to be delivered by March 23, 2022. KCENTRA is a plasma-derived four-factor prothrombin complex concentrate used to treat patients with acquired deficiencies of prothrombin complex coagulation factors due to warfarin or similar vitamin K antagonist therapies. No subcontractors or set-aside designations were identified in the award documentation provided.
Generated 1/2/24, 12:08 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 3/2/22 |